Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DuMed Sverige AB
AB
Active
Org 5591864003
Sjöflygvägen 35 E, 183 62
Täby
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 7 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
DuMed Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
21M
16M
11M
5M
0M
2021: 7M
7M
2021
2022: 16M (+129% vs 2021)
16M
+129%
2022
2023: 17M (+6% vs 2022)
17M
+6%
2023
2024: 11M (-35% vs 2023)
11M
-35%
2024
2025: 17M (+55% vs 2024)
17M
+55%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 1M
1M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
17 355
11 313
16 824
15 958
6 879
Staff expenses
—
—
—
—
—
EBITDA
693
48
100
24
35
Depreciation & amort.
−118
−5
−22
−21
−17
EBIT
575
43
78
3
18
Net financials
3
—
—
−1
−6
Profit before tax
577
42
78
2
13
Tax
−119
−9
−16
−1
−5
Net profit
458
33
62
1
8
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
11 301
4 765
4 477
11 417
1 674
Equity
813
355
322
260
259
Long-term debt
0
0
0
0
0
Short-term debt
10 487
4 410
4 156
11 157
1 415
Total debt
10 487
4 410
4 156
11 157
1 415
Financial ratios
5-year trend
EBITDA margin
4,0 %
This company
15,8 %
Market median
This company
Market median
75% below market
2021
2025
Equity ratio
7,2 %
This company
38,2 %
Market median
This company
Market median
81% below market
2021
2025
Return on equity
56,3 %
This company
18,4 %
Market median
This company
Market median
206% above market
2021
2025
Net profit margin
2,6 %
This company
8,1 %
Market median
This company
Market median
68% below market
2021
2025
Asset turnover
1,54×
This company
1,12×
Market median
This company
Market median
37% above market
2021
2025
Debt / equity
12,90×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on DuMed Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
